Markets Spike as Coronavirus Vaccine Trial Shows 90% Success Rate

Bitcoin and U.S. stock futures shot up on Monday after Pfizer announced positive results from a trial of its coronavirus vaccine.

AccessTimeIconNov 9, 2020 at 1:38 p.m. UTC
Updated Sep 14, 2021 at 10:28 a.m. UTC

Both bitcoin and U.S. stock futures shot up on Monday after a U.S. pharmaceutical giant announced positive results from a large-scale clinical trial of a coronavirus vaccine.

Risk appetite improved as Pfizer said its experimental vaccine has been 90% effective in preventing infections in the ongoing trial, Bloomberg reported. The news raises hopes that there may soon be an effective treatment for COVID-19, which is again running rampant through regions such as the U.S. and Europe.

CoinDesk data shows that as the news broke, bitcoin jumped from $15,500 to $15,840 in the 15 minutes to 12:00 UTC. That came as the futures tied to the S&P 500 surged over 100 points to reach a record high of $3,648, and Dow Jones futures rose 1,500 points.

Gold, meanwhile, fell from $1,950 to $1,900 as investors sold safe-haven assets amid the rally on Wall Street.

The coronavirus pandemic brought the global economy to a near standstill in the second quarter and its recent resurgence is threatening to derail the fragile economic recovery. The vaccine news, therefore, bodes well for growth-sensitive stocks and other risky assets.

While the S&P 500 futures continue to trade near record highs, bitcoin has erased gains to trade near $10,500.

The cryptocurrency's rally from October lows below $10,500 has stalled below $16,000 over the past couple of days. But on Sunday, a weekly close above last year's high opened the door for a continued rally toward bitcoin's $20,000 price record.


Read more about

DISCLOSURE

Please note that our privacy policy, terms of use, cookies, and do not sell my personal information has been updated.

The leader in news and information on cryptocurrency, digital assets and the future of money, CoinDesk is a media outlet that strives for the highest journalistic standards and abides by a strict set of editorial policies. CoinDesk is an independent operating subsidiary of Digital Currency Group, which invests in cryptocurrencies and blockchain startups. As part of their compensation, certain CoinDesk employees, including editorial employees, may receive exposure to DCG equity in the form of stock appreciation rights, which vest over a multi-year period. CoinDesk journalists are not allowed to purchase stock outright in DCG.

Trending

1
CoinDesk - Unknown
How Are Institutions and Companies Investing in Crypto?

From putting bitcoin on their balance sheets to setting up shop in the metaverse, the ways brands and institutions are investing in cryptocurrencies continues to expand.

CoinDesk - Unknown
2
CoinDesk - Unknown
Consensus 2022: Hollywood, Colleges, Conferences vs. Crypto

The state of crypto and economics live from Consensus 2022 in Austin, Texas.

CoinDesk - Unknown
3
CoinDesk - Unknown
Bitcoin se estabiliza cerca de $21K; inversores esperan evitar otra caída el fin de semana

Los analistas se cuestionan si BTC podrá mantenerse por encima del umbral de $20.000 en un clima de desconfianza entre los inversores.

CoinDesk - Unknown
4
CoinDesk - Unknown
Market Wrap: From GBTC Discount to Short Bitcoin ETF, Traders See Reasons for Optimism

It's hard to imagine that data showing traders piling into a trade designed to profit from further bitcoin price declines might be bullish, but that's how some analysts are interpreting the signal.

CoinDesk - Unknown